What is ICBC Investment?

The companies that ICBC invests in are as follows:

ICBC Financial Asset Investment Co., Ltd. (hereinafter referred to as "ICBC Investment") President Zhang Zhenghua said on October 18 that ICBC Investment is confident Implement the state's policy support for private enterprises, provide financial services to Kangmei, and enhance Kangmei's capital strength through debt-for-equity swaps in accordance with laws and regulations.

ICBC Investment President Zhang Zhenghua and his delegation visited Kangmei Pharmaceutical on the 18th, and had special discussions with Ma Xingtian, Chairman and President of Kangmei Pharmaceutical, and other senior executives on promoting strategic cooperation such as market-oriented debt-for-equity swaps, and reached relevant ***knowledge. At the symposium, Zhang Zhenghua made the above remarks.

ICBC Investment is a wholly-owned subsidiary of the Industrial and Commercial Bank of China. It is one of the first domestic market-oriented debt-for-equity swap implementation institutions approved to be established. It has a registered capital of 12 billion yuan and is currently registered by the ICBC Group. The subsidiary with the largest capital base.

Kangmei Pharmaceutical stated that the two parties further implemented the "Head-to-Head Office" Cooperation Agreement signed between Kangmei Pharmaceutical and the Industrial and Commercial Bank of China (hereinafter referred to as "ICBC") in Beijing on the 16th, and its controlling shareholder Kangmei Industrial and ICBC Investment signed the specific contents of the 3 billion yuan "Market-based Debt-for-Equity Swap Cooperation Framework Agreement" and established a special coordination group. ICBC Investment will support Kangmei to further optimize the industrial organization, reduce the asset-liability ratio, and improve operating levels. Deepen industrial upgrading.

ICBC Investment President Zhang Zhenghua (left) held a discussion with Ma Xingtian (right), chairman and president of Kangmei Pharmaceuticals

Zhang Zhenghua and his party visited the exhibition hall of Kangmei Pharmaceuticals to learn about the full range of Kangmei Traditional Chinese Medicine The layout and development of the industry chain's precise service-oriented "smart" health industry across the country, as well as the Kangmei China Traditional Chinese Medicine Price Index and the Kangmei Pharmaceutical Chinese Medicinal Materials Bulk Spot Trading Platform. Zhang Zhenghua also experienced new and convenient "Internet medical and health" models such as "Smart Pharmacy, Smart Medicine Cabinet, and Medicine Gourd App" launched by Kangmei Pharmaceutical.